Levetiracetam
Spritam is a brand-name anticonvulsant medication containing levetiracetam, formulated as an orally disintegrating tablet for easy administration. It is prescribed for the treatment of certain seizure disorders, including partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in patients with epilepsy. This medication is available in various strengths and is typically used as part of a comprehensive seizure management plan.
Spritam is an antiepileptic drug used to treat seizure disorders, delivered in a rapidly dissolving tablet form.
Key facts at a glance
- RxNorm
- 1736038
- Generic
- Spritam
- Class
- brand-name
- Brands
- —
- Availability
- rx
- Lactation
- unknown
- Routes
- —
- Forms
- —
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Spritam is used to treat partial-onset seizures (focal seizures), myoclonic seizures, and primary generalized tonic-clonic seizures in adults and children. It is approved for use as monotherapy or adjunctive therapy and is suitable for patients who have difficulty swallowing traditional tablets.
The exact mechanism of action is not fully established, but levetiracetam is believed to work by binding to synaptic vesicle protein SV2A, which is involved in neurotransmitter release. This action is thought to help reduce abnormal electrical activity in the brain that leads to seizures.
Common side effects may include drowsiness, dizziness, and fatigue. Patients should not discontinue use abruptly, as this may increase seizure frequency. Regular monitoring by a healthcare provider is important, and patients should report any mood changes, depression, or unusual behavior. This medication may interact with other drugs, so patients should disclose all medications to their prescriber.
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 9, 2026. · Read our editorial policy